Medtronic Cardiac Devices

FDA Has Recommended The Expanded Indication of Medtronic's CRT-P and CRT-D
Oct 10, 2013
The US Food and Drug Administration (FDA) advisory panel has recommended the expanded indication of Medtronic’s cardiac resynchronization therapy-pacemakers and -defibrillators (CRT-P and CRT-D) for the treatment of patients who ...

Tags: Medtronic Cardiac Devices, FDA Panel